Costs for colon cancer treatment comparing benefit types and care sources in the US Military Health System

Military Medicine

Volumn 184, Issue 11-12, 2019, Pages e847-e855

  Eaglehouse, Yvonne L ^a,b   Georg, Matthew W ^a   Richard, Patrick ^b   Shriver, Craig D ^a,b   Zhu, Kangmin ^a,b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CLASSIFICATION; COLON TUMOR; ECONOMICS; FEMALE; HEALTH CARE COST; HUMAN; INSURANCE; MALE; MIDDLE AGED; REGISTER; UNITED STATES;

ADULT; COLONIC NEOPLASMS; FEMALE; HEALTH CARE COSTS; HUMANS; INSURANCE BENEFITS; MALE; MIDDLE AGED; MILITARY HEALTH SERVICES; REGISTRIES; UNITED STATES;

EID: 85073321296     PISSN: 00264075     EISSN: 1930613X     Source Type: Journal    
DOI: 10.1093/milmed/usz065     Document Type: Article

References (45)

1. Siegel RL, Miller KD, Jemal A: Cancer statistics, 2019. CA: Cancer J Clin 2019; 69(1): 7-34.
2. Johnson NB, Hayes LD, Brown K, et al: CDC national health report: leading causes of morbidity and mortality and associated behavioral risk and protective factors-United States, 2005-2013. MMWR 2014; 63 (04): 3-27.
3. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML: Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 2011; 103(2): 117-128.
4. DeSantis CE, Lin CC, Mariotto AB, et al: Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 2014; 64(4): 252-271.
5. Yabroff KR, Lund J, Kepka D, Mariotto A: Economic burden of cancer in the United States: estimates, projections, and future research. Cancer Epidemiol Biomarkers Prev 2011; 20(10): 2006-2014.
6. Lee T, Williams VF, Clark LL: Incident diagnoses of cancers in the active component and cancer-related deaths in the active and reserve components, U.S. Armed Forces, 2005-2014. MSMR 2016; 23(7): 23-31.
7. Crawford RJ, Wu J, Park D, Barbour GL: A study of cancer in the military beneficiary population. Mil Med 2007; 172(10): 1084-1088.
8. Dieleman JL, Squires E, Bui AL, et al: Factors associated with increases in us health care spending, 1996-2013. JAMA 2017; 318(17): 1668-1678.
9. Meropol NJ, Schrag D, Smith TJ, et al: American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol 2009; 27(23): 3868-3874.
10. Jansen DJ. Military Medical Care: Questions and Answers. In: Congressional Research Service, ed. Vol 7-5700. www.crs.gov2014
11. Defense Health Agency. TRICARE. 2016; www.tricare.mil.
12. Military Health System and Defense Health Agency. Rates and Reimbursement. 2017; health.mil/military-health-topics/business-support/rates-And-reimbursement; accessed April 5, 2017
13. Defense Health Agency, Defense Health Cost Assessment and Program Evaluation. Evaluation of the TRICARE Program: Access, Cost, and Quality. http://www.tricare.mil/tma/studieseval.aspx2014
14. Eaglehouse YL, Manjelievskaia J, Shao S, et al: Costs for breast cancer care in the military health system: an analysis by benefit type and care source. Mil Med 2018; 183(11-12): e500-e508.
15. American Cancer Society: Cancer Facts & Figures 2017. Atlanta, GA, American Cancer Society, 2017.
16. American Cancer Society. Estimated Number of New Cancer Cases and Deaths by Sex, US, 2017. Cancer Facts & Figures 2017; www.cancer. org
17. Benson AB 3rd, Venook AP, Cederquist L, et al: Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2017; 15(3): 370-398.
18. Benson AB 3rd, Venook AP, Bekaii-Saab T, et al: Colon Cancer, Version 3.2014. J Natl Compr Canc Netw 2014; 12(7): 1028-1059.
19. Benson AB 3rd, Venook AP, Bekaii-Saab T, et al: Rectal Cancer, Version 2.2015. J Natl Compr Canc Netw 2015; 13(6): 719-728; quiz 728.
20. Yabroff KR, Warren JL, Schrag D, et al: Comparison of approaches for estimating incidence costs of care for colorectal cancer patients. Med Care 2009; 47(7 Suppl 1): S56-63.
21. Brown ML, Riley GF, Schussler N, Etzioni R: Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care 2002; 40(8 Suppl): IV-17.
22. Brown ML, Riley GF, Potosky AL, Etzioni RD: Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer. Med Care 1999; 37(12): 1249-1259.
23. The Department of Defense Joint Pathology Center. DoD Cancer Registry Program. 2014; https://www.jpc.capmed.mil, 2017.
24. Defense Health Agency. Military Health System Data Repository. https://www.health.mil/Military-Health-Topics/Technology/Clinical-Support/Military-Health-System-Data-Repository; accessed 26 October, 2017
25. Enewold L, McGlynn KA, Zahm SH, et al: Surveillance mammography among female Department of Defense beneficiaries: a study by race and ethnicity. Cancer 2013; 119(19): 3531-3538.
26. Enewold LR, McGlynn KA, Zahm SH, et al: Breast reconstruction after mastectomy among Department of Defense beneficiaries by race. Cancer 2014; 120(19): 3033-3039.
27. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40(5): 373-383.
28. American Joint Committee on Cancer: Part III: Digestive System, 12: Colon and Rectum. In: AJCC Cancer Staging Manual, Vol. 6, pp. 113-123. Edited by Greene FL, Page DL, Fleming ID, et al, Chicago, Illinois, United States of America: Springer;2002
29. United States Department of Labor. Consumer Price Index. Archived Consumer Price Index Detailed Report 2017; www.bls.gov/cpi. Accessed April 3, 2017.
30. Le Cook B, Manning WG: Thinking beyond the mean: a practical guide for using quantile regression methods for health services research. Shanghai Arch Psychiatry 2013; 25(1): 55-59.
31. Olsen CS, Clark AE, Thomas AM, Cook LJ: Comparing least-squares and quantile regression approaches to analyzing median hospital charges. Acad Emerg Med 2012; 19(7): 866-875.
32. Trade Agreements Act of 1979. In: United States Congress, ed. Title 19, Pub. L. 96-39, 93 Stat. 1441979.
33. Defense Health Agency. TRICARE Pharmacy Program Overview. https://tricare.mil/coveredservices/pharmacy February 2017 2017
34. Jacobson M, O'Malley AJ, Earle CC, Pakes J, Gaccione P, Newhouse JP: Does reimbursement influence chemotherapy treatment for cancer patients? Health Aff (Millwood) 2006; 25(2): 437-443.
35. Hornbrook MC, Malin J, Weeks JC, Makgoeng SB, Keating NL, Potosky AL: Did changes in drug reimbursement after the medicare modernization act affect chemotherapy prescribing? J Clin Oncol 2014; 32(36): 4042-4049.
36. Robinson JC: Value and payment for oncology in the United States. Ann Pharm Fr 2013; 71(5): 285-290.
37. Woolhandler S, Himmelstein DU: Costs of care and administration at for-profit and other hospitals in the United States. N Engl J Med 1997; 336(11): 769-774.
38. Kongstvedt PR: Essentials of Managed Health Care, 6th edn, Burlington, MA, Jones & Bartlett Learning, 2013.
39. Fuchs VR: The basic forces influencing costs of medical care. In: Essays in the Economics of Health and Medical Care, pp 39-50. Edited by Fuchs VR. National Bureau of Economic Research, 1972.
40. Lang K, Lines LM, Lee DW, Korn JR, Earle CC, Menzin J: Trends in healthcare utilization among older Americans with colorectal cancer: a retrospective database analysis. BMC Health Serv Res 2009; 9: 227.
41. Yabroff KR, Mariotto AB, Feuer E, Brown ML: Projections of the costs associated with colorectal cancer care in the United States, 2000-2020. Health Econ 2008; 17(8): 947-959.
42. Velji S, Patel K, Chaudhry B, Grizzle S, Lyons CA, Lilenbaum R: Understanding total cost of cancer care to determine strategic interventions to improve value. J Clin Oncol 2016; 34(7-suppl): 4.
43. Bradley CJ, Yabroff KR, Warren JL, Zeruto C, Chawla N, Lamont EB: Trends in the treatment of metastatic colon and rectal cancer in elderly patients. Med Care 2016; 54(5): 490-497.
44. Dor A, Koroukian S, Xu F, Stulberg J, Delaney C, Cooper G: Pricing of surgeries for colon cancer: patient severity and market factors. Cancer 2012; 118(23): 5741-5748.
45. Hoverman JR, Cartwright TH, Patt DA, et al: Pathways, outcomes, and costs in colon cancer: retrospective evaluations in 2 distinct databases. Am J Manag Care 2011; 17(Suppl 5 Developing): Sp45-52.